KR880009015A - 알리머켑토아세틸시드논이민, 이의 제조방법 및 이의 용도 - Google Patents
알리머켑토아세틸시드논이민, 이의 제조방법 및 이의 용도 Download PDFInfo
- Publication number
- KR880009015A KR880009015A KR1019880000504A KR880000504A KR880009015A KR 880009015 A KR880009015 A KR 880009015A KR 1019880000504 A KR1019880000504 A KR 1019880000504A KR 880000504 A KR880000504 A KR 880000504A KR 880009015 A KR880009015 A KR 880009015A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- alkyl
- allyl
- pharmaceutically acceptable
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (8)
- 일반식 (I)의 알릴머켑토아세틸시드논이민 및 이의 약물학적으로 허용되는 염.상기식에서, R1은 일반식또는또는 -N(R3)2의 2급 아미노 그룹이며, X는또는 (CH2)n이고, R2는 래디칼 R3OOC-, R4SO2 -, 또는 탄소수 1 내지 4의 알킬이며, n은 0,1 또는 2이고, R3는 탄소수 1 내지 4의 알킬이며, R4는 R3또는 (R3)2N-이다.
- 제1항에 있어서, R1이 래디칼이고, X가 NR2ㆍSO2또는 O이며, R2가 R3OOC- 또는 R4SO2 -이고, R3가 메틸 또는 에틸이며, R4가 메틸에틸, 디메틸아미노 또는 디에틸아미노인 알릴머켑토 아세틸시드논이민.
- 제1항에 있어서, R1이인 알릴머켑토아세틸시드논이민.
- 제1항에 있어서, R1이인 알릴머켑토아세틸시드논아민.
- (a) 일반식 (II)의 시드논이민(경우에 따라 염형태이다)을 알릴머켑토아세틸 래디칼을 도입하는 아실화제와 반응시키거나, (b) 일반식 (II)의 시드논이민(경우에 따라 염형태이다)을, 후속하여 알릴 머켑탄과 반응하여 일반식 (I)의 알리머켑토화학물을 제공하는 래디칼을 함유하는 아세트산 유도체로 아실화시킴을 특징으로 하여, 일반식 (I)의 알릴머켑토아세틸시드논이민을 제조하는 방법.상기식에서, R1은 일반식또는또는 -N(R3)2의 2급 아미노 그룹이며, X는또는 (CH2)n이고, R2는 래디칼 R3OOC-, R4SO2-, 또는 탄소수 1 내지 4의 알킬이며, n은 0,1 또는 2이고, R3는 탄소수 1 내지 4의 알킬이며, R4는 R3또는 (R3)2N-이다.
- 심장혈관질환 또는 협심증 치료를 위한 약물학적 활성 화합물로서의, 일반식 (I)의 알릴머켑토아세틸시드논이민 또는 이의 약제학적으로 허용되는 산부가염.
- 약제학적으로 허용되는 부형제 및 첨가제와 함께, 경우에 따라 다른 약제학적 활성화합물과 함께, 활성화합물로서, 일반식 (I)의 알릴머켑토아세틸시드논이민 또는 이의 약물학적으로 허용되는 산부가염을 함유함을 특징으로 하는 약제.
- 심장혈관질환 또는 협심증 치료용 약제의 제조를 위한, 일반식 (I)의 알릴머켑토아세틸시드논이민 또는 이의 약물학적으로 허용되는 산부가염의 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP3702083.8 | 1987-01-24 | ||
DE19873702083 DE3702083A1 (de) | 1987-01-24 | 1987-01-24 | Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
KR880009015A true KR880009015A (ko) | 1988-09-13 |
Family
ID=6319474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880000504A KR880009015A (ko) | 1987-01-24 | 1988-01-23 | 알리머켑토아세틸시드논이민, 이의 제조방법 및 이의 용도 |
Country Status (13)
Country | Link |
---|---|
US (1) | US4888333A (ko) |
EP (1) | EP0276710B1 (ko) |
JP (1) | JPS63201177A (ko) |
KR (1) | KR880009015A (ko) |
AT (1) | ATE70837T1 (ko) |
CA (1) | CA1309408C (ko) |
DE (2) | DE3702083A1 (ko) |
DK (1) | DK640687A (ko) |
ES (1) | ES2038700T3 (ko) |
GR (1) | GR3003738T3 (ko) |
HU (1) | HU203331B (ko) |
PH (1) | PH24709A (ko) |
ZA (1) | ZA88446B (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3702083A1 (de) * | 1987-01-24 | 1988-08-04 | Cassella Ag | Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung |
US5221680A (en) * | 1988-01-14 | 1993-06-22 | Cassella Aktiengesellschaft | Substituted 3-aminosydnonimines |
DE3800830A1 (de) * | 1988-01-14 | 1989-07-27 | Cassella Ag | Substituierte 3-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung |
DE4015236A1 (de) * | 1990-05-13 | 1991-11-14 | Cassella Ag | Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung |
DE3820210A1 (de) * | 1988-06-14 | 1989-12-21 | Cassella Ag | Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung |
DE3921460A1 (de) * | 1989-06-30 | 1991-01-03 | Cassella Ag | Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung |
DE4028679A1 (de) * | 1990-09-10 | 1992-03-19 | Cassella Ag | Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung |
DE4031373A1 (de) * | 1990-10-04 | 1992-04-09 | Cassella Ag | 3-piperazino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung |
AU3632393A (en) * | 1992-03-24 | 1993-10-21 | Cassella Aktiengesellschaft | Use of sydnonimines to treat erectile dysfunction |
WO1998047896A1 (fr) * | 1997-04-22 | 1998-10-29 | Chugai Seiyaku Kabushiki Kaisha | Derives de sydononimine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2930736A1 (de) * | 1979-07-28 | 1981-02-12 | Cassella Ag | Pharmakologisch wirksame, substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung |
DE3107933A1 (de) * | 1981-03-02 | 1982-09-16 | Cassella Ag, 6000 Frankfurt | Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung |
JPS5859977A (ja) * | 1981-10-06 | 1983-04-09 | Banyu Pharmaceut Co Ltd | 新規なn−アシルシドノンイミン誘導体およびその製法 |
DE3526068A1 (de) * | 1985-07-20 | 1987-01-22 | Cassella Ag | Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische praeparate |
DE3702083A1 (de) * | 1987-01-24 | 1988-08-04 | Cassella Ag | Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung |
-
1987
- 1987-01-24 DE DE19873702083 patent/DE3702083A1/de not_active Withdrawn
- 1987-12-07 DK DK640687A patent/DK640687A/da not_active Application Discontinuation
-
1988
- 1988-01-16 DE DE8888100574T patent/DE3867073D1/de not_active Expired - Fee Related
- 1988-01-16 AT AT88100574T patent/ATE70837T1/de not_active IP Right Cessation
- 1988-01-16 EP EP88100574A patent/EP0276710B1/de not_active Expired - Lifetime
- 1988-01-16 ES ES198888100574T patent/ES2038700T3/es not_active Expired - Lifetime
- 1988-01-22 HU HU88254A patent/HU203331B/hu not_active IP Right Cessation
- 1988-01-22 ZA ZA880446A patent/ZA88446B/xx unknown
- 1988-01-22 PH PH36391A patent/PH24709A/en unknown
- 1988-01-22 CA CA000557105A patent/CA1309408C/en not_active Expired - Fee Related
- 1988-01-22 JP JP63011031A patent/JPS63201177A/ja active Pending
- 1988-01-23 KR KR1019880000504A patent/KR880009015A/ko not_active Application Discontinuation
- 1988-08-10 US US07/230,846 patent/US4888333A/en not_active Expired - Fee Related
-
1992
- 1992-02-06 GR GR920400078T patent/GR3003738T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA1309408C (en) | 1992-10-27 |
HU203331B (en) | 1991-07-29 |
ES2038700T3 (es) | 1993-08-01 |
HUT50142A (en) | 1989-12-28 |
DE3702083A1 (de) | 1988-08-04 |
EP0276710A1 (de) | 1988-08-03 |
PH24709A (en) | 1990-10-01 |
JPS63201177A (ja) | 1988-08-19 |
ZA88446B (en) | 1988-07-22 |
DE3867073D1 (de) | 1992-02-06 |
GR3003738T3 (ko) | 1993-03-16 |
ATE70837T1 (de) | 1992-01-15 |
US4888333A (en) | 1989-12-19 |
EP0276710B1 (de) | 1991-12-27 |
DK640687A (da) | 1988-06-25 |
DK640687D0 (da) | 1987-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890013035A (ko) | 인돌로카르바졸 유도체와 그 제조방법 및 그들을 함유하는 약제조성물 | |
ES2040373T3 (es) | Esteroides puenteados en 19,11beta, su preparacion y preparados farmaceuticos que contienen estos compuestos. | |
KR880002834A (ko) | α-알킬-4-아미노-3-퀴놀린메탄올 및 1-(4-아르알킬아미노-3-퀴놀리닐) 알칸온, 이의 제조방법 및 약제로서의 용도 | |
KR940011475A (ko) | 신규한 에리트로마이신 유도체, 그의 제조 방법 및 의약으로서의 그의 용도 | |
KR910004581A (ko) | 신규 화합물들 | |
KR920003968A (ko) | 염증성 장 질환의 치료방법 | |
ATE63124T1 (de) | Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung. | |
KR880009015A (ko) | 알리머켑토아세틸시드논이민, 이의 제조방법 및 이의 용도 | |
KR950032267A (ko) | 11,21-비스페닐-19-노르프레그난 유도체 | |
KR890011596A (ko) | 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도 | |
KR900006347A (ko) | 살균성 플루오로퀴놀로닐 세펨 | |
KR910000607A (ko) | 새로운 에스테르 | |
KR930000483A (ko) | [(아릴알킬피페리딘-4-일)메틸]-2a,3,4,5-테트라 하이드로-1(2H)-아세나프틸렌-1-온 및 관련 화합물, 이의 제조방법 및 약제로서의 이의 용도 | |
KR930007914A (ko) | 제1위치에 에테르 또는 티오에테르 그룹을 함유하는 프탈라진 및 이의 제조방법 | |
KR890001965A (ko) | 스퍼구알린 관련 유도체 | |
PT93126A (pt) | Processo para a preparacao de eteres carboxialquilicos da 2-amino-7- -hidroxitetralina | |
KR920007995A (ko) | 벤즈아미드 유도체 | |
KR900016178A (ko) | 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물 | |
KR930006003A (ko) | 이미다졸릴메틸-피리딘류 화합물 | |
KR970706825A (ko) | 헬리코박터의 감염에 기인하는 질환의 치료제(remedy for diseases caused by infection with helicobacter) | |
ATE70838T1 (de) | Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung. | |
KR890002111A (ko) | 벤즈이미다졸 유도체, 그의 제법 및 치료에의 이용 | |
DK247389D0 (da) | Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse | |
US3635971A (en) | 3 (3 4-dihydro-3-oxo-2-quinoxalinyl) propionamides | |
KR840006810A (ko) | 세팔로스포린 에스테르의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |